Stock Rating Downgrade The Value Trend Rating for Silvercrest Asset Management Gro (NASDAQ: SAMG) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]
What is the market’s view of Adobe’s future operating performance as reflected in the current price of $507? Over the next 6 years, Adobe shares will need to reach $851 to achieve average annual stock […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Preformed Line Products Co (NASDAQ: PLPC) weakened recently. PLPC’s current Value Trend Rating is D and the prior Rating was […]
Stock Rating Upgrade In the last week the Value Trend Rating for MKS Instruments Inc (NASDAQ: MKSI) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action MKS Instruments Inc […]
Stock Rating Upgrade The Value Trend Rating for Fonar Corp (NASDAQ: FONR) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Recent meaningful negative changes in fundamentals have affected Donegal Group Inc (NASDAQ: DGICA): the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased significantly. Important […]
Stock Rating Downgrade In recent days the Value Trend Rating for Dollar Tree Inc (NASDAQ: DLTR) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 3/18/24, Dollar Tree […]
Stock Rating Downgrade The Value Trend Rating for Daktronics Inc (NASDAQ: DAKT) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Downgrade The Value Trend Rating for CareDx Inc (NASDAQ: CDNA) weakened in the last week from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]
Stock Rating Upgrade The Value Trend Rating for CASI Pharmaceuticals Inc (NASDAQ: CASI) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research